Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248335 · ClinicalTrials.gov registry record · Phase 4
Effect of Obesity on Proton Pump Inhibitors
A Phase 4 study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
NCT04248335 is a Phase 4 study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 76 participants.
The verdict
NCT04248335, a Phase 4 study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
Study Summary
This longitudinal study tests the hypothesis that obesity affects drug pharmacology of acid suppression medications in children.
Interventions
- DRUG Midazolam
- DRUG Pantoprazole
- DRUG Lansoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2018-07-03 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04248335
The ClinicalTrials.gov registry entry for NCT04248335 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT04248335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04248335 about?
NCT04248335 is a clinical study titled "Effect of Obesity on Proton Pump Inhibitors". This longitudinal study tests the hypothesis that obesity affects drug pharmacology of acid suppression medications in children.
What is the current status of trial NCT04248335?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2018-07-03. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04248335?
The interventions under investigation include: Midazolam (DRUG), Pantoprazole (DRUG), Lansoprazole (DRUG).
Who is sponsoring clinical trial NCT04248335?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.